Trulieve Cannabis Corp. (TRLV) SEC Filings & Earnings Calls

Deconsolidation of Harvest creates one-time loss and operational complexity.

“Reported net loss attributable to common shareholders of $406 million or $2.10 per share, includes $407 million impact from the Harvest deconsolidation and equity investment.” · word for word

Regulatory dependence on cannabis rescheduling and state-level expansion.

“Filed applications to register state licensed medical marijuana operations with the Drug Enforcement Agency following federal rescheduling of medical marijuana to Schedule III.” · word for word

Deconsolidation Transaction Risk

“Loss on deconsolidation transaction expense for the three months ended June 30, 2026 was $403.3 million and was attributable to the Deconsolidation Transaction completed during the quarter.” · word for word

Pricing Pressure in Mature Markets

“Excluding the impact of the Deconsolidation Transaction, revenue was also affected by continued pricing pressure in certain mature markets, partially offset by revenue growth in Ohio through the Deconsolidation Transaction date.” · word for word

Shareholder rights may be reduced under Delaware law

“shareholders should note that the Delaware Domestication includes certain permitted changes to the Company's governing documents which alter the relative rights of shareholders and management and which may reduce shareholder participation in certain corporate decisions.” · word for word

Increased litigation risk in Delaware

“following the Delaware Domestication, the Company may be subject to a heightened risk of securities class actions or derivative lawsuits, which can result in substantial costs and divert management time and resources, even if such class actions or lawsuits are without merit.” · word for word

Delaware Domestication may not be completed

“The completion of the Delaware Domestication is subject to the approval of the Arrangement Resolution by shareholders and the receipt of the Final Order from the Court. There can be no assurance that the Delaware Domestication will be completed.” · word for word

Leadership vacuum risk; potential disruption to strategic execution.

“President departure without immediate successor named.”

Regulatory uncertainty despite rescheduling; DEA registration process may face delays or challenges.

“Rescheduling to Schedule III; applications filed but hearing not until June 29, 2026.”

Revenue decline and margin compression signal competitive pressure or demand softness.

“Revenue down 4% YoY; gross margin down 300bps; adjusted EBITDA down 8%.”

Adult-use cannabis remains federally illegal

“Until that process is complete, the Company's adult use cannabis operations remain illegal under U.S. federal law.” · word for word

Continued price compression in retail

“The decrease in retail revenue reflects continued price compression, partially offset by contributions from new retail dispensary openings” · word for word

Revenue flat YoY; net loss still significant at $116M; reliance on regulatory rescheduling for future growth.

“Revenue flat at $1.181B; net loss $116M; management cites rescheduling as key catalyst.”

Cannabis federal illegality risk

“cannabis remains illegal under U.S. federal law.” · word for word

Price compression in retail

“The decrease in retail revenue was driven by price compression.” · word for word

High tax burden

“Provision for income taxes as a percentage of gross profit was 29.3% for the year ended December 31, 2025.” · word for word

Significant debt obligations

“Total contractual obligations $929.4 million as of December 31, 2025.”

Cannabis Federal Illegality

“However, cannabis remains illegal under U.S. federal law.” · word for word

Price Compression

“The increase in revenue was driven by new store openings, adult use sales in Ohio and wholesale growth, which was partially offset by price compression.” · word for word

High Tax Burden (280E)

“The provision for income taxes as a percentage of gross profit was 31.2% for the three months ended September 30, 2025.” · word for word

Gross margin compression from 61% to 59% YoY; potential pricing pressure in cannabis market.

“Gross margin 59% vs 61% in Q3 2024.”

Net loss continues, though improved; adjusted net loss unchanged YoY.

“Net loss $27M; adjusted net loss $12M.”

Revenue growth minimal (+1% YoY); sequential decline from Q2 2025 ($302M to $288M).

“Revenue $288M vs $284M YoY; $302M in Q2 2025.”